SVASE Event: 'VC Breakfast: The Foundry: Focus On Medical Devices And Health-care Markets' September 7, 2006

Event: 'VC Breakfast: The Foundry: Focus On Medical Devices And Health-care Markets'

Date: Thursday, September 07, 2006 At 08:00
Duration: 1 Hour 30 Minutes
Contact Info:
VCBC Chair: Jai Kumar, contact no. - 408-406-4693 Email: [email protected]
URL: www.svase.org/index.php?option=com_extcalendar&Itemid=149&extmode=view&extid=524

The featured VC will be Hank Plain, Vice Chairman, The Foundry. www.thefoundry.com/

EVENT LOCATION: Law Offices of O'Melveny & Myers, 2765 Sand Hill Road, Menlo Park, CA 94025

This event is co-sponsored by O'Melveny & Myers LLP www.omm.com.

The Foundry
The Foundry is the premier medical device incubator for inventors to rapidly transform their concepts into companies.
The Foundry is a highly experienced team of technical and seniro executives who have, prior to joining The Foundry, created medical device businesses generating over $2.5 billion of value for their founders and investors. Since 1998, nine companies have been founded and financed through The Foundry, further establishing a proven track record of success. The Foundry is a full-capability incubator, with resources spanning all functional areas and a fully equipped medical device development facility. The Foundry literally becomes the new company throughout the critical seed stage.

Hank Plain
Hank Plain serves as an active Director and Advisor of early stage medical device companies,providing expertise in founding, funding, product development and operational management. In July 2000, Mr. Plain joined The Foundry, Inc. as Vice Chairman.

Mr. Plain was Chairman of the Board of Embolic Protection, Inc., helping to negotiate the acquisition of EPI by Boston Scientific in 2001. He was also a Director of TransVascular, Inc., which was acquired by Medtronic in 2003. Previously, Mr. Plain was President and CEO of Perclose. From 1993 until May 2000, Mr. Plain led Perclose from the product concept stage through product development, regulatory approvals and successful market launch to become the worldwide leader in vascular access
site closure devices with over $100 million in sales in 2000. Mr. Plain successfully directed Perclose through an IPO, a secondary offering and acquisition by Abbott
Laboratories in November 1999. Prior to joining Perclose, Mr. Plain was with Eli Lilly and Company for 12 years. He held various marketing and general management positions in the Pharmaceutical and Medical Device business units.

Mr. Plain is Chairman of the Board of Directors for Emphasys Medical, Satiety and Xtent. He is a Director of Acclarent, Access Closure, Ardian, Cabochon Aesthetics, Cierra, The Foundry, and the Pacific Foundation for Cardiovascular Research.

COST: $25 SVASE Members; $39 Affiliates; $49 Non-members. This event is for ENTREPRENEURS ONLY, BY PREREGISTRATION ONLY.

This event is co-sponsored by O'Melveny & Myers LLP www.omm.com.

CONTACT: VCBC Chair: Jai Kumar, contact no. - 408-406-4693

LOCATION: Law Offices of O'Melveny & Myers, 2765 Sand Hill Road, Menlo Park, CA 94025